A Study to Determine the Incidence of Atrial and Ventricular Arrhythmias in Patients with Hypertrophic Cardiomyopathy

Overview

About this study

The purpose of this study is to determine the incidence of atrial and ventricular arrhythmias in patients with hypertrophic cardiomyopathy, with and without sleep apnea.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Currently or previously enrolled in 17-003514 and/or 16-009474
At least 18 years of age
Prior diagnosis of hypertrophic cardiomyopathy (HCM)
Willing to give informed consent

Exclusion Criteria:

Vulnerable study population
Known atrial fibrillation
Implanted with a PPM or ICD
Pregnancy

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Jeffrey Geske, M.D.	Open for enrollment	Contact information: Sleep and Cardiovascular Clinical Research Unit CPL@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Jeffrey Geske, M.D.

Open for enrollment

Contact information:

Sleep and Cardiovascular Clinical Research Unit

CPL@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials